Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Immunology

How RALD Affects the Body: Symptoms and Clinical Findings

At a Glance

RALD often causes an enlarged spleen, persistently high monocytes (a type of white blood cell), and swollen lymph nodes, but severity varies. Some people develop immune attacks on red cells or platelets or more infections, so monitoring and spleen-safety precautions are important.

While the genetic cause of RALD is invisible, its effects on the body are tangible. Because the RAS mutation alters how cells grow and survive, immune cells eventually begin to crowd the blood and organs, leading to a specific set of clinical findings. Understanding these symptoms can help you and your care team track how the condition is evolving.

The Core Triplets: Spleen, Blood, and Lymph Nodes

Most people diagnosed with RALD share three primary physical and laboratory findings based on published case series.

  • Splenomegaly (Enlarged Spleen): The spleen is an organ that filters blood and stores immune cells. In RALD, the spleen often becomes enlarged because it is working overtime [1]. This occurs in the vast majority of reported cases and can sometimes be massive [2]. An enlarged spleen may cause a feeling of “fullness” in the upper left side of the abdomen or make you feel full quickly after eating.
  • Persistent Monocytosis: This is a hallmark of RALD [2]. It means your blood consistently shows a high number of monocytes—a type of white blood cell [1]. While a high count usually signals a temporary infection in most people, in RALD, it is an ongoing state.
  • Lymphadenopathy (Swollen Lymph Nodes): Like the spleen, lymph nodes act as hubs for the immune system. They often become swollen (palpable) as they fill with excess immune cells [3][4].

Safety Warning: Protecting an Enlarged Spleen

Because the spleen is enlarged and fragile, it is at risk of rupture. You must ask your clinician about avoiding contact sports, heavy lifting, or activities with a risk of abdominal trauma. Seek immediate emergency medical care if you experience sudden, severe left-upper-abdominal pain, pain radiating to your left shoulder, severe dizziness, or fainting, especially after a fall or injury.

When the Immune System Attacks Itself

In RALD, the immune system is often dysregulated. It may begin to identify healthy parts of your own body as foreign and attack them. This is called autoimmunity, and it most frequently targets your blood cells—a condition known as autoimmune cytopenia [2].

  • Attacking Red Blood Cells (Hemolytic Anemia): If the immune system destroys red blood cells faster than the body can replace them, it causes anemia [5]. Symptoms include pale skin, significant fatigue, and shortness of breath.
  • Attacking Platelets (Thrombocytopenia): Platelets help your blood clot. When they are attacked, your count drops, which can lead to easy bruising, nosebleeds, or small red/purple spots on the skin called petechiae [3].

These autoimmune attacks can be intermittent, occurring in “flares” that require temporary treatment, or they can be chronic and require ongoing management [6][7].

Immune Deficiency and Infection Risk

Despite having high numbers of some immune cells, RALD can be associated with an immune deficiency in some patients, though this risk is highly variable.

  • Variable Risk: Not every patient with RALD has a severe immune deficiency. Your individual risk depends on your specific immune workup (such as immunoglobulin levels, neutrophil counts, and how well you respond to vaccines), as well as treatments you may take, like steroids or rituximab [8].
  • Types of Infections: Some reported cases involve recurrent typical infections (like sinus or ear infections), while very rare case reports have documented unusual or severe infections [8][9]. Do not assume you are inevitably immunocompromised; work with an immunologist to assess your personal risk.

A Spectrum of Severity

It is important to remember that RALD does not look the same for everyone. The disease exists on a broad spectrum:

  1. Indolent (Mild) Course: Many patients have a “slow” version of the disease, feeling generally well and requiring only regular observation without aggressive medication [1].
  2. Moderate to Severe Course: Other patients may deal with frequent autoimmune flares (like drops in platelets), severe multi-organ inflammation, or infections that require specific treatments [8][10].

Your medical team will use your unique “clinical phenotype”—your specific mix of symptoms and blood work—to decide how closely you need to be monitored and when treatment should be considered.

Common questions in this guide

What are the most common signs of RALD?
The core findings are an enlarged spleen, a persistently high number of monocytes (a type of white blood cell), and swollen lymph nodes. Some people also have autoimmune problems affecting red blood cells or platelets, fatigue, bruising, or recurrent infections.
What should I do if I have an enlarged spleen from RALD?
Ask your clinician which activities are safe, because an enlarged spleen can be fragile and may rupture after abdominal trauma. Seek emergency medical care immediately for sudden severe pain in the upper left abdomen, pain that spreads to the left shoulder, severe dizziness, or fainting, especially after an injury.
What does persistent monocytosis mean in RALD?
Persistent monocytosis means that blood tests repeatedly show a high number of monocytes rather than a temporary rise during an infection. It is a hallmark of RALD and is followed with regular blood-count monitoring.
Can RALD cause anemia or low platelets?
Yes. RALD-related autoimmunity can destroy red blood cells, causing hemolytic anemia with fatigue, pale skin, or shortness of breath, or can lower platelets, causing bruising, nosebleeds, or tiny red or purple skin spots called petechiae. These problems may occur in flares or persist over time.
Does RALD increase the risk of infections?
Some people with RALD have immune deficiency and recurrent infections, but the risk varies and not everyone has a severely weakened immune system. Clinicians assess immunoglobulin levels, neutrophil counts, vaccine responses, and treatments such as steroids or rituximab to estimate individual risk.
How severe can RALD be?
RALD ranges from an indolent course in which a person feels well and needs observation to a more serious course with autoimmune flares, inflammation affecting several organs, or infections needing treatment. Symptoms and blood results help the medical team decide how closely to monitor a person and when treatment may be needed.

Get notified when new evidence is published on RAS-associated autoimmune leukoproliferative disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.

    Calvo KR, Price S, Braylan RC, et al.

    Blood 2015; (125(18)):2753-8 doi:10.1182/blood-2014-11-567917.

    PMID: 25691160
  2. 2

    Clinical Spectrum of Ras-Associated Autoimmune Leukoproliferative Disorder (RALD).

    Neven Q, Boulanger C, Bruwier A, et al.

    Journal of clinical immunology 2021; (41(1)):51-58 doi:10.1007/s10875-020-00883-7.

    PMID: 33011939
  3. 3

    [Ras-associated autoimmune leukoproliferative disorder: a report of 2 cases and literature review].

    He TY, Li CR, Xia Y, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2017; (55(11)):853-857 doi:10.3760/cma.j.issn.0578-1310.2017.11.013.

    PMID: 29141318
  4. 4

    RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children.

    Wang W, Zhou Y, Zhong L, et al.

    Pediatric rheumatology online journal 2019; (17(1)):55 doi:10.1186/s12969-019-0346-1.

    PMID: 31412876
  5. 5

    Weekly Rituximab Followed by Monthly Rituximab Treatment for Autoimmune Disease Associated With RAS-associated Autoimmune Leukoproliferative Disease.

    Toyoda H, Deguchi T, Iwamoto S, et al.

    Journal of pediatric hematology/oncology 2018; (40(8)):e516-e518 doi:10.1097/MPH.0000000000001276.

    PMID: 30080751
  6. 6

    Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD).

    Papa R, Rusmini M, Schena F, et al.

    Clinical immunology (Orlando, Fla.) 2021; (231()):108837 doi:10.1016/j.clim.2021.108837.

    PMID: 34455097
  7. 7

    Case Report: Haemopoietic stem cell transplantation in refractory paediatric RAS-associated lymphoproliferative disorder.

    Senthil S, Matalliotakis MG, Hughes S, et al.

    Frontiers in immunology 2026; (17()):1850700 doi:10.3389/fimmu.2026.1850700.

    PMID: 42344933
  8. 8

    Recurrent and unusual infections unmasking a rare inborn error of immunity: a case report RAS-associated Autoimmune Lymphoproliferative Disease (RALD).

    Ahmad Shawaludin MQ, Nik MAC, Zainudeen ZT, et al.

    BMC pediatrics 2026; (26(1)).

    PMID: 42337451
  9. 9

    Case Report: RAS-associated autoimmune leukoproliferative disorder presenting with early-onset liver failure in a 9-month-old Chinese girl.

    Zheng L, Li D, Zhang T

    Frontiers in pediatrics 2026; (14()):1943641 doi:10.3389/fped.2026.1943641.

    PMID: 42839954
  10. 10

    The importance of considering monogenic causes of autoimmunity: A somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus.

    Ragotte RJ, Dhanrajani A, Pleydell-Pearce J, et al.

    Clinical immunology (Orlando, Fla.) 2017; (175()):143-146 doi:10.1016/j.clim.2016.12.006.

    PMID: 28043923

This page is for informational purposes only and does not constitute medical advice. Because RALD symptoms and infection risk vary, consult your clinician or immunologist about monitoring, activity precautions, and urgent warning signs.